Akebia Therapeutics (AKBA) Misses Q1 EPS by 22c, Revenues Miss
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
| AKEBIA THERAPEUTICS (NASDAQ: AKBA) | Delayed: 0.66 +0.02 (3.13%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.64 | 52 Week High | $13.20 | |||
| Open | $0.64 | 52 Week Low | $7.00 | |||
| Day High | $0.68 | P/E | N/A | |||
| Day Low | $0.63 | EPS | $0.00 | |||
| Volume | 5,390,189 | |||||
